{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:04:46Z","timestamp":1792098286289,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1993,9,1]],"date-time":"1993-09-01T00:00:00Z","timestamp":746841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":8132,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[1993,9]]},"DOI":"10.1038\/ki.1993.292","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T06:37:37Z","timestamp":1180075057000},"page":"638-642","source":"Crossref","is-referenced-by-count":234,"title":["The increased risk of coronary heart disease associated with nephrotic syndrome"],"prefix":"10.1016","volume":"44","author":[{"given":"Juan D.","family":"Ordo\u00f1ez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Hiatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen J.","family":"Killebrew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce H.","family":"Fireman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.1993.292_bb0010","series-title":"The Kidney","first-page":"1182","article-title":"Primary glomerular diseases","author":"Glassock","year":"1991"},{"key":"10.1038\/ki.1993.292_bb0015","first-page":"946","article-title":"Experimental reconstruction of metabolic pattern of lipid nephrosis: Key role of hepatic protein synthesis in hyperlipidemia","volume":"9","author":"Marsh","year":"1960","journal-title":"Metabolism"},{"issue":"Suppl 31","key":"10.1038\/ki.1993.292_bb0020","first-page":"S8","article-title":"Hyperlipidemia of the nephrotic syndrome","volume":"39","author":"Kaysen","year":"1991","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1993.292_bb0025","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ki.1988.125","article-title":"Lovastatin therapy in nephrotic hyperlipidemia: Effects on lipoprotein metabolism","volume":"33","author":"Vega","year":"1988","journal-title":"Kidney Int"},{"issue":"5N","key":"10.1038\/ki.1993.292_bb0030","first-page":"45N","article-title":"The hyperlipidemia of the nephrotic syndrome","volume":"87","author":"Appel","year":"1989","journal-title":"Am J Med"},{"key":"10.1038\/ki.1993.292_bb0035","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0140-6736(69)90110-X","article-title":"Ischaemic heart-disease as a complication of nephrotic syndrome","volume":"2","author":"Berlyne","year":"1969","journal-title":"Lancet"},{"key":"10.1038\/ki.1993.292_bb0040","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5694\/j.1326-5377.1974.tb93641.x","article-title":"Increased incidence of coronary heart disease associated with combined elevation of serum triglyceride and cholesterol concentrations in the nephrotic syndrome in man","volume":"2","author":"Alexander","year":"1974","journal-title":"Med J Aust"},{"key":"10.1038\/ki.1993.292_bb0045","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5694\/j.1326-5377.1976.tb140529.x","article-title":"Incidence of coronary heart disease associated with nephrotic syndrome","volume":"1","author":"Gilboa","year":"1976","journal-title":"Med J Aust"},{"key":"10.1038\/ki.1993.292_bb0050","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00005792-197007000-00004","article-title":"Lipoid nephrosis in 31 adult patients: Renal biopsy study by light, electron and fluorescence microscopy with experience in treatment","volume":"49","author":"Hopper","year":"1970","journal-title":"Medicine"},{"key":"10.1038\/ki.1993.292_bb0055","doi-asserted-by":"crossref","first-page":"855","DOI":"10.5694\/j.1326-5377.1974.tb93714.x","article-title":"Hyperlipidaemia in renal disease","volume":"2","author":"Vosnides","year":"1974","journal-title":"Med J Aust"},{"key":"10.1038\/ki.1993.292_bb0060","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0140-6736(79)92067-1","article-title":"Does the nephrotic syndrome increase the risk of cardiovascular disease","volume":"2","author":"Wass","year":"1979","journal-title":"Lancet"},{"key":"10.1038\/ki.1993.292_bb0065","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000182024","article-title":"The nephrotic syndrome and ischaemic heart disease","volume":"27","author":"Mallick","year":"1981","journal-title":"Nephron"},{"key":"10.1038\/ki.1993.292_bb0070","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0140-6736(79)92587-X","article-title":"Nephrotic syndrome and cardiovascular disease","volume":"2","author":"Wardle","year":"1979","journal-title":"Lancet"},{"key":"10.1038\/ki.1993.292_bb0075","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2105\/AJPH.72.8.829","article-title":"Characteristics of patients referred for treatment of end-stage renal disease in a defined population","volume":"72","author":"Hiatt","year":"1982","journal-title":"Am J Public Health"},{"key":"10.1038\/ki.1993.292_bb0080","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2105\/AJPH.82.5.703","article-title":"Overcoming the absence of socioeconomic data in medical records: Validation and application of a census-based methodology","volume":"82","author":"Krieger","year":"1992","journal-title":"Am J Public Health"},{"key":"10.1038\/ki.1993.292_bb0085","series-title":"International Classification of Diseases","author":"US Department of Health, Education, and Welfare","year":"1693"},{"key":"10.1038\/ki.1993.292_bb0090","unstructured":"(9th rev) Clinical Modification (2nd ed) Washington, DC, GPO, 1980; Section 581.0-.9, DHHS Publication No. (PHS) 80 1260 US Deparmtment of Health and Human Services International Classification of Diseases"},{"key":"10.1038\/ki.1993.292_bb0095","series-title":"Cardiovascular Survey Methods","first-page":"123","author":"Rose","year":"1982"},{"key":"10.1038\/ki.1993.292_bb0100","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.2105\/AJPH.74.12.1324","article-title":"The California Automated Mortality Linkage System (CAMLIS)","volume":"74","author":"Arellano","year":"1984","journal-title":"Am J Public Health"},{"key":"10.1038\/ki.1993.292_bb0105","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000182025","article-title":"Cardiovascular disease and the nephrotic syndrome: The other side of the coin","volume":"27","author":"Wass","year":"1981","journal-title":"Nephron"},{"key":"10.1038\/ki.1993.292_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-74-1-1","article-title":"Serum cholesterol, lipoproteins, and the risk of coronary artery disease: The Framingham study","volume":"74","author":"Kannel","year":"1971","journal-title":"Ann Intern Med"},{"key":"10.1038\/ki.1993.292_bb0115","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0272-6386(86)80164-0","article-title":"Treatment of the hyperlipidemia of the nephrotic syndrome: A controlled trial","volume":"8","author":"Valeri","year":"1986","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.1993.292_bb0120","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000184524","article-title":"Effect of probucol on hyperlipidemia in patients with nephrotic syndrome","volume":"47","author":"Iida","year":"1987","journal-title":"Nephron"},{"key":"10.1038\/ki.1993.292_bb0125","first-page":"200","article-title":"Effective and safe short term improvement in nephrotic hypercholesterolemia with HMG CoA reductase inhibitor mevinolin","volume":"31","author":"Golper","year":"1987","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1993.292_bb0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5694\/j.1326-5377.1974.tb93639.x","article-title":"Is control of hyperlipidaemia important in renal diseases","volume":"2","year":"1974","journal-title":"Med J Aust"},{"key":"10.1038\/ki.1993.292_bb0135","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/ki.1991.22","article-title":"Lipid abnormalities in renal disease","volume":"39","author":"Appel","year":"1991","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1993.292_bb0140","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000413122","article-title":"The epidemiology of coronary artery disease in patients on maintenance hemodialysis: Implications for management","volume":"52","author":"Rostand","year":"1986","journal-title":"Contrib Nephrol"},{"issue":"5N","key":"10.1038\/ki.1993.292_bb0145","first-page":"3N","article-title":"Rationale and management of hyperlipidemia of the nephrotic syndrome","volume":"87","author":"Grundy","year":"1989","journal-title":"Am J Med"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815581738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815581738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T22:22:36Z","timestamp":1635546156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815581738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,9]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1993,9]]}},"alternative-id":["S0085253815581738"],"URL":"https:\/\/doi.org\/10.1038\/ki.1993.292","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[1993,9]]}}}